Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 56
Filtrar
1.
J Affect Disord ; 198: 72-7, 2016 07 01.
Artigo em Inglês | MEDLINE | ID: mdl-27011362

RESUMO

BACKGROUND: This study intended to determine whether certain traits of temperament are associated with former and current ADHD symptomatology in a non-clinical sample of 18 year old males. METHODS: We performed a cross sectional descriptive study of 3280 men during the examination for military service. The investigation included a socio-demographic questionnaire, screening for substance abuse, temperament (TEMPS-M), past (WURS) and current (ADHD symptom checklist) ADHD symptomatology. RESULTS: We found a correlation of cyclothymic (p<.001), irritable (p<.001) and anxious (p<.05) temperament with occurrence and severity of past and present ADHD symptomatology. No significant correlation has been detected for hyperthymic and depressive temperament. Judged retrospectively, ADHD symptoms were strongly consistent over time. LIMITATIONS: The sample consists of men only. These had to be fit enough to be enlisted for military service; men with severe mental or physical disorders were thus excluded. Furthermore, the cross-sectional study design does not allow making conclusions about the temporal relationships between ADHD symptoms and substance misuse. CONCLUSIONS: These results indicate that a temperament based approach towards those affected by ADHD might be useful. Subtyping ADHD by integrating temperament profiles in diagnosis and treatment of the disorder could help explain some of the heterogeneity of the disease.


Assuntos
Envelhecimento/psicologia , Transtorno do Deficit de Atenção com Hiperatividade/psicologia , Temperamento , Adolescente , Adulto , Transtorno Bipolar/diagnóstico , Estudos Transversais , Humanos , Masculino , Inventário de Personalidade/estatística & dados numéricos , Inquéritos e Questionários
3.
J Affect Disord ; 165: 203-7, 2014 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-24882201

RESUMO

AIMS: The first aim of this study is to investigate the impact of different temperaments in opiate dependency patients. The second aim of this study is to define therapy relevant subgroups in opiate addiction for further basic clinical research and therapy. METHODS: In the time period from September to November 2010, 101 patients (72 males and 29 females) which fulfilled the diagnosis of opiate dependency according to DSM-IV-TR were recruited consecutively. All patients were in treatment at the Oum El Nour rehabilitation center/Lebanon (Inpatient and Outpatient groups). Lesch Alcoholism Typology modified for assessment of opiate addicts, and the briefTEMPS-M, Arabic version were used. RESULTS: The organic Type IV group was the most prevalent (48.5%) among the sample followed by the Affective Type III group (41.6%) and the minority represented the two other types (I & II). The organic Type IV group represented the major type in the cyclothymic and anxious temperament. In the contrary the other two groups (I & II) were the minority among the cyclothymics.


Assuntos
Transtornos Relacionados ao Uso de Opioides/psicologia , Transtornos Relacionados ao Uso de Opioides/terapia , Temperamento , Adulto , Estudos Transversais , Manual Diagnóstico e Estatístico de Transtornos Mentais , Feminino , Humanos , Masculino , Adulto Jovem
4.
J Affect Disord ; 141(2-3): 399-405, 2012 Dec 10.
Artigo em Inglês | MEDLINE | ID: mdl-22475473

RESUMO

BACKGROUND: Suicide is a major health problem accounting for up to 1.5 percent of all deaths worldwide and represents one of the most common causes of death in adolescents and young adults. A number of studies has been performed to establish risk factors for suicide in patients with psychiatric disorders including temperamental features. This study set out to assess the relationship between suicidal ideation and temperament in young adults. METHODS: A cross-sectional sample of healthy college students (n=1381) was examined using a self-rating questionnaire. Suicidal ideation, social background, educational status, substance abuse, and affective temperament according to TEMPS-M were assessed. Predictors of lifetime suicidal ideation were examined in multivariate logistic regression analyses. RESULTS: Suicidal ideation was reported by 12.5% of all subjects at some point in their life and was higher in nicotine dependents, youth with alcohol related problems and users of illicit substances as well as in youth with lower educational status. Lifetime suicidal ideation was associated with the anxious, depressive and cyclothymic temperament in both sexes and the irritable temperament in males. These results remained significant after adjustment for smoking status, frequency of alcohol consumption, drug experience and educational status in a multivariate logistic regression analysis. LIMITATIONS: The use of self-rating instruments always reduces objectivity and introduces the possibility of misreporting. CONCLUSIONS: Considering the fact that many subjects completing suicide have never been diagnosed with mental disorders it might be reasonable to include an investigation of temperament in screenings for risk of suicide. This might be especially useful for health care professionals without mental health care background.


Assuntos
Estudantes/psicologia , Ideação Suicida , Temperamento , Adolescente , Adulto , Áustria , Estudos Transversais , Escolaridade , Feminino , Humanos , Masculino , Transtornos Mentais/psicologia , Fatores de Risco , Transtornos Relacionados ao Uso de Substâncias/psicologia , Suicídio/psicologia , Suicídio/estatística & dados numéricos , Tentativa de Suicídio/prevenção & controle , Tentativa de Suicídio/psicologia , Tentativa de Suicídio/estatística & dados numéricos , Universidades , Adulto Jovem , Prevenção do Suicídio
5.
J Affect Disord ; 135(1-3): 177-83, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21840604

RESUMO

AIMS: The aim of this study was to assess the impact of temperamental traits in alcohol dependent patients on the course of illness. METHODS: The case files of 116 alcohol dependent patients, according to ICD-10 and DSM-IV-TR, were examined retrospectively. All patients were in treatment between 02/08 and 03/09 at the Psychiatric Department of the General Hospital Vienna, either at the alcohol outpatient clinic or the psychiatric ward, which has the treatment focus on alcohol dependence. The brief TEMPS-M auto-questionnaire was used to assess the temperamental distribution. The dimensions of alcohol dependence have been assessed using the Lesch Alcoholism Typology, a computerized structured interview. The potential effect of temperamental scores on various outcomes describing the course of illness is investigated using multi-variable regression models. RESULTS: Cyclothymic score was the only temperament which significantly influenced the age of onset of alcohol abuse and age of onset of alcohol dependence. Backward selection among temperaments exhibits depressive temperament as most important effect regarding the likelihood of suicide-attempts in the patient's case history and anxious temperament as most important effect regarding having psychiatric treatment focusing on alcohol dependence prior to current in- or outpatient stay. LIMITATIONS: The sample size of this study is small compared to the number of investigated outcomes and temperaments. Further, a healthy control group, matched for age and gender, was not available for comparison of the temperament sub-scores. CONCLUSION: Dominant cyclothymic, but also depressive and anxious temperament, seem to be negative predictors for the course of illness in alcohol dependence. Regarding positive long term outcome specific evidence based medical treatment approaches are needed for these patients.


Assuntos
Alcoolismo/psicologia , Transtorno Bipolar/psicologia , Temperamento , Adulto , Idade de Início , Idoso , Ansiedade/psicologia , Estudos de Casos e Controles , Depressão/genética , Transtorno Depressivo/genética , Transtorno Depressivo/psicologia , Manual Diagnóstico e Estatístico de Transtornos Mentais , Feminino , Humanos , Classificação Internacional de Doenças , Idioma , Masculino , Pessoa de Meia-Idade , Transtornos do Humor/genética , Transtornos do Humor/psicologia , Inventário de Personalidade/estatística & dados numéricos , Fenótipo , Prognóstico , Unidade Hospitalar de Psiquiatria , Estudos Retrospectivos , Tentativa de Suicídio
6.
J Affect Disord ; 133(1-2): 93-6, 2011 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-21497914

RESUMO

BACKGROUND: During the last 20 years Austrian psychiatric services underwent fundamental changes, as a focus was set on downsizing psychiatric hospitals. Little is known about how restructuring of mental health services affected patients with major depression and suicide rates. METHODS: Monthly hospital discharges from all hospitals in Austria with the diagnosis of unipolar major depression as primary reason for inpatient treatment were obtained for the time period between 1989 and 2008. These data were correlated with relevant parameters from the general health system, such as number of hospital beds, suicide rate, density of psychotherapists and sales of antidepressants. RESULTS: While the number of psychiatric beds was reduced by almost 30%, the total annual numbers of inpatient treatment episodes for depression increased by 360%. This increase was stronger for men than for women. Further on this development was accompanied by a decrease in the suicide rate and an improvement in the availability of professional outpatient mental health service providers. LIMITATIONS: Only aggregated patient data and no single case histories were available for this study. The validity of the correct diagnosis of unipolar major depression must be doubted, as most likely not all patients were seen by a clinical expert. CONCLUSIONS: Our data show that although inpatient treatment for unipolar major depression dramatically increased, reduction of psychiatric beds did not lead to an increase of suicide rates.


Assuntos
Serviços Comunitários de Saúde Mental/estatística & dados numéricos , Transtorno Depressivo Maior/terapia , Número de Leitos em Hospital/estatística & dados numéricos , Hospitalização/estatística & dados numéricos , Hospitais Psiquiátricos/organização & administração , Alta do Paciente/estatística & dados numéricos , Suicídio/estatística & dados numéricos , Idoso , Áustria , Depressão , Transtorno Depressivo/terapia , Feminino , Humanos , Pacientes Internados , Masculino , Pessoa de Meia-Idade , Pacientes Ambulatoriais , Redução de Pessoal , Reprodutibilidade dos Testes
7.
Pharmacopsychiatry ; 40(4): 140-5, 2007 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-17694475

RESUMO

INTRODUCTION: Sexual dysfunction is a common side effect of antipsychotic medication. Although increased prolactin levels caused by antipsychotic agents are believed to play a major role with regard to sexual side effects, the underlying mechanism of antipsychotic agent-induced sexual dysfunction remains poorly understood. METHODS: In a multicentric study 587 psychiatric inpatients were assessed by means of a self-rating sexual questionnaire. Focussing on antipsychotic treatment three subgroups were drawn from the original sample. One group was treated with prolactin-increasing antipsychotics (n=119), the other with prolactin-neutral medication (n=109) and the third patient group was comprised of non-medicated clinical controls (n=105). RESULTS: The majority of all patients (50-75%) reported at least minor sexual dysfunction. On comparison of the subgroups, only female patients treated with prolactin-increasing medication reported more severe sexual dysfunction. However, multiple regression analysis did not confirm an association between the type of treatment and sexual impairment. DISCUSSION: Sexual dysfunction frequently occurs in psychiatric inpatients treated with antipsychotics. Our findings only partly support the assumptions concerning a major role of prolactin-increasing neuroleptics for medication-induced sexual impairment.


Assuntos
Antipsicóticos/efeitos adversos , Transtornos Psicóticos/tratamento farmacológico , Esquizofrenia/tratamento farmacológico , Disfunções Sexuais Fisiológicas/induzido quimicamente , Adulto , Humanos , Libido , Masculino , Prolactina/metabolismo , Inquéritos e Questionários
8.
Pharmacopsychiatry ; 40(2): 58-63, 2007 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-17447174

RESUMO

INTRODUCTION: Although sexual side effects are a common reason for noncompliance with medication, information on impairment of sexuality in psychiatric inpatients is scarce. METHODS: In the present multi-center study, data on several aspects of sexual functioning were collected in psychiatric inpatients using a previously validated questionnaire. RESULTS: A high overall prevalence of sexual dysfunction was reported by participants and was highest in depressed subjects. Patients receiving antidepressants suffered from more frequent and more severe impairment of sexuality than did subjects receiving neither antidepressants nor antipsychotics or opioids. DISCUSSION: Judging from this data, sexual impairment appears to be a frequent and underestimated problem in psychiatric inpatients with a high prevalence across all diagnostic groups, particularly in depressed subjects. Female patients attribute this impairment mainly to their mental illness, whereas male patients tend to assign their impairments primarily to their medication.


Assuntos
Antidepressivos/efeitos adversos , Transtorno Depressivo/complicações , Transtorno Depressivo/tratamento farmacológico , Disfunções Sexuais Psicogênicas/etiologia , Adulto , Fatores Etários , Analgésicos Opioides/efeitos adversos , Analgésicos Opioides/uso terapêutico , Antidepressivos/uso terapêutico , Antipsicóticos/efeitos adversos , Antipsicóticos/uso terapêutico , Feminino , Humanos , Masculino , Transtornos Mentais/complicações , Transtornos Mentais/tratamento farmacológico , Prevalência , Fatores Sexuais , Disfunções Sexuais Psicogênicas/induzido quimicamente , Disfunções Sexuais Psicogênicas/epidemiologia , Inquéritos e Questionários
9.
Pharmacopsychiatry ; 37(5): 200-5, 2004 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-15470798

RESUMO

OBJECTIVE: The aim of our study was to assess the possible relationship between event-related potentials (ERP) and serotonergic or noradrenergic activity in depression. Therefore, we were interested in the impact of different monoamine reuptake inhibitors on ERP. METHODS: Thirty-six inpatients with major depression were treated with either reboxetine (n = 17) or citalopram (n = 19) in a prospective randomized study. Before and after four weeks of treatment, visually-evoked ERP were investigated. Twenty-two patients completed the study. Monoaminergic function was determined by oral reboxetine and citalopram challenge tests. RESULTS: P3 latency significantly decreased after a four-week treatment with either drug. There was no significant difference in the decrease of P3 latency between both drugs. We detected a significant inverse correlation between serotonergic hypofunction before treatment and the P3 latency (r = -0.739, p = 0.001). CONCLUSIONS: These results show that, in depressed patients, the P3 latency is decreased by antidepressive treatment. Furthermore, the results suggest that P3 latency might depend on the serotonergic rather than the noradrenergic system.


Assuntos
Inibidores da Captação Adrenérgica/farmacologia , Inibidores da Captação Adrenérgica/uso terapêutico , Citalopram/farmacologia , Citalopram/uso terapêutico , Transtorno Depressivo Maior/tratamento farmacológico , Potenciais Evocados Visuais/efeitos dos fármacos , Morfolinas/farmacologia , Morfolinas/uso terapêutico , Inibidores Seletivos de Recaptação de Serotonina/farmacologia , Inibidores Seletivos de Recaptação de Serotonina/uso terapêutico , Adolescente , Adulto , Eletroculografia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Reboxetina
10.
Psychol Med ; 33(7): 1277-84, 2003 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-14580081

RESUMO

BACKGROUND: The dorsolateral prefrontal cortex (DLPFC) is involved in the pathophysiology of major depression. In particular, metabolic (functional hypometabolism) and structural alterations have been described. In this study metabolic changes within the DLPFC of severely depressed patients before and after electroconvulsive therapy (ECT) were evaluated by proton STEAM spectroscopy (1H-MRS). METHOD: Twelve severely depressed patients with a diagnosis of major depressive episode, unipolar with melancholic features (DSM-IV), were enrolled, and the left dorsolateral prefrontal cortex (DLPFC) was investigated before and after unilateral ECT by 1H-MRS. Three of the four non-responding patients were remeasured a third time after a combined ECT/antidepressant pharmacotherapy. The results were compared with 12 age- and gender-matched controls. RESULTS: In depressed patients reduced glutamate/glutamine (Glx) levels were measured pre-ECT; Glx concentrations correlated negatively with severity of depression. After successful treatment, Glx increased significantly and levels no longer differed from those of age-matched controls. CONCLUSIONS: Our results indicate that major depressive disorder is accompanied by state-dependent metabolic alterations, especially in glutamate/glutamine metabolism, which can be reversed by successful ECT.


Assuntos
Transtorno Depressivo Maior/terapia , Dominância Cerebral/fisiologia , Eletroconvulsoterapia , Metabolismo Energético/fisiologia , Espectroscopia de Ressonância Magnética , Córtex Pré-Frontal/fisiopatologia , Idoso , Mapeamento Encefálico , Transtorno Depressivo Maior/fisiopatologia , Feminino , Ácido Glutâmico/metabolismo , Glutamina/metabolismo , Humanos , Interpretação de Imagem Assistida por Computador , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Valores de Referência
11.
Nervenarzt ; 74(1): 55-70; quiz 70-1, 2003 Jan.
Artigo em Alemão | MEDLINE | ID: mdl-12596029

RESUMO

On the basis of epidemiology, neurobiology and clinical observation, the classification of bipolar disorders has shown considerable development and expansion in recent years. In particular, the recognition of mixed states, the introduction of bipolar II disorders, increasing awareness of the diagnosis of hypomania, as well as the interest in cyclothymic disorders and temperament have led to a shift in diagnostic attitudes in the USA, as well as in European countries. In this article, the possible clinical and scientific benefits of such tendencies are discussed, as are the risks of broadening bipolar disorders beyond DSM-IV. Also demonstrated is how several "modern" concepts of bipolarity have deep roots in the history of German psychiatry; a mixity scale based on Kraepelin's classification of affective mixed states is presented.


Assuntos
Transtorno Bipolar/diagnóstico , Transtorno Bipolar/classificação , Transtorno Bipolar/psicologia , Comorbidade , Transtorno Ciclotímico/classificação , Transtorno Ciclotímico/diagnóstico , Transtorno Ciclotímico/psicologia , Diagnóstico Diferencial , Manual Diagnóstico e Estatístico de Transtornos Mentais , Seguimentos , Humanos , Classificação Internacional de Doenças , Transtornos Mentais/classificação , Transtornos Mentais/diagnóstico , Transtornos Mentais/psicologia , Temperamento
13.
Am J Psychiatry ; 158(5): 802-4, 2001 May.
Artigo em Inglês | MEDLINE | ID: mdl-11329406

RESUMO

OBJECTIVE: Pharmacogenetic influences on therapeutic response to neuroleptic treatment are poorly understood. This study investigates the association of response to short-term haloperidol treatment with a Taq I polymorphism in the DRD2 gene. METHOD: Fifty-seven patients with acute psychosis were treated with haloperidol for up to 28 days. Improvement and response were measured by using the Positive and Negative Syndrome SCALE: Forty-one patients were homozygous for allele 2, and 16 were heterozygous. RESULTS: Heterozygous patients showed a greater improvement in positive, but not in negative, symptoms on all treatment days than patients homozygous for allele 2. Differences in improvement of positive symptoms reached statistical significance on days 14, 21, and 28. On treatment day 14, 10 (62.5%) of 16 heterozygous patients had at least 50% improvement of positive symptoms, compared with 11 (28.9%) of 38 homozygous patients. CONCLUSIONS: These results support the hypothesis that genetic variations in the DRD2 gene may influence the individual response to antipsychotics.


Assuntos
Haloperidol/uso terapêutico , Polimorfismo Genético , Transtornos Psicóticos/tratamento farmacológico , Receptores de Dopamina D2/genética , Adulto , Relação Dose-Resposta a Droga , Esquema de Medicação , Feminino , Haloperidol/farmacologia , Humanos , Desequilíbrio de Ligação , Masculino , Farmacogenética , Escalas de Graduação Psiquiátrica/estatística & dados numéricos , Psicoses Induzidas por Substâncias/diagnóstico , Psicoses Induzidas por Substâncias/tratamento farmacológico , Transtornos Psicóticos/diagnóstico , Esquizofrenia/diagnóstico , Esquizofrenia/tratamento farmacológico , Resultado do Tratamento
14.
Psychiatr Prax ; 28(1): 43-4, 2001 Jan.
Artigo em Alemão | MEDLINE | ID: mdl-11236335

RESUMO

OBJECTIVE: Depression is a common problem in neurological rehabilitation. Although three double-blind studies have shown the efficacy of trazodone, citalopram and nortriptyline, antidepressant drug therapy of poststroke depression is not yet considered a state-of-the-art strategy. In a hospital for neurological rehabilitation we have performed an open study on the effects of the SSRI, paroxetine, in depressive disorders caused by neurological diseases. METHOD: 111 consecutive admissions were screened for depression and 9 patients were admitted to the study having a HDRS score > or = 14. RESULTS: 10-40 mg of paroxetine were well tolerated and led to a > or = 50% reduction of the HDRS score in 8/9 patients. A patient with pathological crying, but without depression, was also successfully treated with 20 mg of paroxetine. CONCLUSIONS: We conclude that the SSRI, paroxetine, is an effective and well-tolerated therapy of depressive disorders caused by various neurological diseases, including also other diagnoses than stroke.


Assuntos
Encefalopatias/psicologia , Transtorno Depressivo/reabilitação , Paroxetina/administração & dosagem , Acidente Vascular Cerebral/psicologia , Adulto , Idoso , Encefalopatias/reabilitação , Transtorno Depressivo/psicologia , Relação Dose-Resposta a Droga , Esquema de Medicação , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Paroxetina/efeitos adversos , Reabilitação do Acidente Vascular Cerebral , Resultado do Tratamento
17.
Neuropsychobiology ; 42 Suppl 1: 50-1, 2000.
Artigo em Inglês | MEDLINE | ID: mdl-11093073

RESUMO

Topiramate is a newly developed anticonvulsant agent with possible mood-stabilizing properties. Little is known about the short- and long-term effects of topiramate monotherapy in bipolar disorder. We here present the case of a 60-year-old female bipolar patient who received topiramate alone as maintenance treatment after recovering from euphoric mania. During 7 months, she was free from new manic symptomatology and she was able to reduce her overweight by 16.5 kg. The patient who is known to have a strongly hyperthymic temperament described symptoms of fatigue and sedation and eventually discontinued topiramate monotherapy. When she presented again in our bipolar clinic, severe euphoric mania had developed. After hospitalization, she slowly responded to oral sodium valproate loading plus zotepine. Her weight increased again and so did her triglyceride serum levels. Topiramate treatment and discontinuation did not seem to affect cholesterol serum levels.


Assuntos
Afeto/efeitos dos fármacos , Transtorno Bipolar/tratamento farmacológico , Peso Corporal/efeitos dos fármacos , Frutose/análogos & derivados , Lipídeos/sangue , Fármacos Neuroprotetores/uso terapêutico , Adulto , Transtorno Bipolar/classificação , Transtorno Bipolar/psicologia , Feminino , Frutose/efeitos adversos , Frutose/uso terapêutico , Humanos , Fármacos Neuroprotetores/efeitos adversos , Topiramato
18.
Acta Psychiatr Scand ; 102(4): 310-3, 2000 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11089733

RESUMO

OBJECTIVE: It is our objective to examine the phenomenon of mad scenes in bel canto opera from a modern perspective. METHOD: The development of psychiatry and music at the beginning of the 19th century is described. Common elements of romantic music and mental disorders are discussed. It is shown how bel canto composers represent psychiatric illness by musical means. The psychopathology depicted in a prototypical mad scene is evaluated. RESULTS: Early romantic music is characterized by imagination, illusion and loss of structure; characteristics which can be well expressed in mad scenes. While madness (withdrawal into a utopian world) gained a certain attraction in society, clinical psychiatry increasingly focused on emotional causes of illness and on drug-induction of mental disorders. CONCLUSION: Mad scenes in bel canto opera can be understood as expression of an increasing interest in emotional aspects in music and society as well as in clinical psychiatry.


Assuntos
Medicina na Literatura , Transtornos Mentais/história , Música/história , História do Século XIX , Humanos
19.
Mol Psychiatry ; 5(2): 193-5, 2000 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-10822348

RESUMO

There is abundant evidence that the serotonin (5-HT) system is modulating mood and several behavioural traits and that disturbances in the regulation of this system can be associated with severe behavioural malfunctions, as aggressive implusive and suicidal behaviour.1 Recently a functional polymorphism in the promoter region of the serotonin transporter gene (5-HTTLPR) was identified2 and the presence of one or two short alleles was associated with anxiety-related personality traits3 and several psychiatric disturbances, such as affective disorder4 or severe alcohol dependence.5 With respect to the importance of the 5-HT transporter in serotonergic transmission, we have genotyped the DNA of 58 Caucasian suicide victims (with unknown psychiatric diagnoses) and 110 healthy controls for the biallelic functional polymorphism in the 5-HTTLPR. We found a highly significant increased frequency of suicide victims being carriers of one or two short alleles (Fisher's Exact Test, two sided, P = 0.0003), which suggests that a genetically altered protein function within the serotonergic pathway might be involved in suicidality, independently from the clinical diagnosis.


Assuntos
Proteínas de Transporte/genética , Glicoproteínas de Membrana/genética , Proteínas de Membrana Transportadoras , Polimorfismo Genético , Suicídio , Alelos , Feminino , Triagem de Portadores Genéticos , Genótipo , Alemanha , Humanos , Masculino , Pessoa de Meia-Idade , Proteínas do Tecido Nervoso/genética , Valores de Referência , Proteínas da Membrana Plasmática de Transporte de Serotonina , Violência , População Branca
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...